StockNews.com Downgrades LeMaitre Vascular (NASDAQ:LMAT) to Hold

StockNews.com lowered shares of LeMaitre Vascular (NASDAQ:LMAT – Free Report) from a buy rating to a hold rating in a research note released on Saturday. Several other research firms have also issued reports on LMAT. Barrington Research raised their price objective on LeMaitre Vascular from $69.00 to $79.00 and gave the company an outperform rating […]

Related Keywords

Canada ,Stifel Nicolaus ,Lawrencej Jasinski ,Georgew Lemaitre ,Lemaitre Vascular ,Securities Exchange Commission ,Keycorp ,Vanguard Group Inc ,Lemaitre Vascular Inc ,Cynosure Group ,Barrington Research ,Canada Life Assurance ,Lemaitre Vascular Company Profile ,Quadrature Capital Ltd ,Summit Creek Advisors ,Free Report ,Moderate Buy ,Maitre Vascular ,Get Free Report ,Exchange Commission ,Director Lawrence ,Capital Ltd ,Creek Advisors ,Vanguard Group ,Lemaitre Vascular Daily ,